|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.305 USD | +4.30% |
|
-5.62% | +38.96% |
| Market Cap | 412M 358M 330M 309M 578M 39.49B 590M 3.94B 1.52B 19.04B 1.55B 1.52B 66.19B | P/E Ratio 2026 * |
-4.58x | P/E Ratio 2027 * | -4.14x |
|---|---|---|---|---|---|
| Enterprise Value | 412M 358M 330M 309M 578M 39.49B 590M 3.94B 1.52B 19.04B 1.55B 1.52B 66.19B | EV / Sales 2026 * |
3,837x | EV / Sales 2027 * | 2,475x |
| Free-Float |
93.01% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ovid Therapeutics Inc.
| 1 day | +4.30% | ||
| 1 week | -5.62% | ||
| Current month | -17.03% | ||
| 1 month | -21.08% | ||
| 3 months | +12.69% | ||
| 6 months | +38.11% | ||
| Current year | +38.96% |
| 1 week | 2.16 |  | 2.5 |
| 1 month | 2.16 | | 2.9 |
| Current year | 1.36 | | 3.1 |
| 1 year | 0.27 | | 3.1 |
| 3 years | 0.24 | | 4.14 |
| 5 years | 0.24 | | 4.64 |
| 10 years | 0.24 | | 15.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 2025-12-31 | |
Jeffrey Rona
DFI | Director of Finance/CFO | 56 | 2021-06-01 |
Petra Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 2025-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Levin
CHM | Chairman | 72 | 2014-03-31 |
Karen Bernstein
BRD | Director/Board Member | 73 | 2015-09-29 |
Bart Friedman
BRD | Director/Board Member | 81 | 2015-11-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-06 | Free | Director | 17,578 | 0.0133% | ||
| 04-06 | Free | Director | 8,789 | 0.0067% | ||
| 04-06 | Free | Director | 17,578 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.30% | -5.62% | +682.92% | -38.62% | 412M | |
| +0.90% | +2.17% | +54.73% | +111.51% | 55.58B | |
| +0.03% | +0.33% | +49.22% | +43.94% | 43.47B | |
| +0.28% | +1.79% | -14.54% | -18.34% | 22.64B | |
| +0.97% | +3.27% | +0.44% | +399.00% | 20.96B | |
| +3.81% | -5.07% | +12.00% | -29.52% | 15.79B | |
| +0.28% | +0.78% | +9.40% | -39.87% | 15.3B | |
| +0.34% | +1.92% | +28.55% | +181.35% | 13.45B | |
| +5.27% | +5.54% | +14.25% | - | 11.74B | |
| -5.27% | -0.43% | +87.77% | +208.02% | 10.96B | |
| Average | +1.10% | -1.47% | +92.47% | +90.83% | 21.03B | |
| Weighted average by Cap. | +0.73% | +0.74% | +33.24% | +99.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 108K 93.29K 85.99K 80.57K 151K 10.29M 154K 1.03M 397K 4.96M 404K 395K 17.25M | 167K 145K 133K 125K 233K 15.96M 238K 1.59M 616K 7.69M 626K 612K 26.75M |
| Net income | -77.12M -66.93M -61.69M -57.8M -108M -7.38B -110M -736M -285M -3.56B -290M -283M -12.38B | -89.84M -77.96M -71.86M -67.34M -126M -8.6B -128M -857M -332M -4.15B -337M -330M -14.42B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 2.265 $ | +2.49% | 146,291 |
| 26-06-11 | 2.210 $ | -3.07% | 2,883,375 |
| 26-06-10 | 2.280 $ | -5.79% | 1,607,475 |
| 26-06-09 | 2.420 $ | +2.54% | 1,483,639 |
| 26-06-08 | 2.360 $ | -1.67% | 1,471,464 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
Select your edition
All financial news and data tailored to specific country editions
